Posted in

News

“Can we use ‘personalized’ medicine to prevent T1D?”

Watch the seminar presented by Michael Haller, MD, Professor & Chief of Pediatric Endocrinology and UFDI Affiliate at the Naomi Berry Diabetes Center – Columbia University. https://diabetes.ufl.edu/wordpress/files/2021/01/zoom_2.mp4…

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes The UFDI team is dedicated to improving the lives of people affected by type 1 diabetes (T1D). Over the last 25 years, UFDI investigators have played a major role in nearly every clinical trial that has demonstrated a novel…

Dr. Stabler awarded R01 grant from the NIH NIDDK

Congratulations to Cherie Stabler, Ph.D., professor in the J. Crayton Pruitt Family Department of Biomedical Engineering, for receiving a $1.7 million RO1 grant from the NIH National Institute of Diabetes and Digestive and Kidney Diseases for her project, “Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants.”…